David Gerber, M.D. Titles and Appointments Co-Director, Simmons Comprehensive Cancer Center Office of Education and Training Professor Endowed Title David Bruton, Jr. Professorship in Clinical Cancer Research Schools Medical School Departments Internal Medicine | Public Health Biography David Gerber, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of the Division of Hematology and Oncology. He serves as Co-Director of Education and Training in the Harold C. Simmons Comprehensive Cancer Center. Originally from Chicago, Dr. Gerber holds a bachelor's degree in history from Yale University in New Haven, Connecticut, where he graduated cum laude. He earned his medical degree at Cornell University Medical College in New York and completed his internship and residency in internal medicine at UT Southwestern, where he served as Chief Resident. He then received advanced training through a fellowship in medical oncology at Johns Hopkins University School of Medicine in Baltimore. Certified by the American Board of Internal Medicine in medical oncology, Dr. Gerber joined the UT Southwestern faculty in 2007. He is invested in helping patients have a better quality of life. Dr. Gerber is active in research related to lung cancer, including clinical trials. His research has generated more than 250 publications that he has authored or co-authored, including articles and book chapters. His studies have contributed to invitations to lecture both nationally and internationally. He serves on several committees at UT Southwestern. Beyond the institution, he serves as Chair of the Clinical Trials Advisory Committee for the Cancer Prevention and Research Institute of Texas (CPRIT) and is a member of the National Comprehensive Cancer Network (NCCN) Oncology Research Program Investigator Steering Committee. Dr. Gerber holds memberships in several professional organizations, and he has been honored with numerous awards, including being named a Best Doctor in Dallas by D Magazine during the years of 2011-2023. Education Medical Education Weill Cornell Graduate School of Medical Science (2000) Residency UT Southwestern Medical Center (2004), Internal Medicine Fellowship Johns Hopkins Hospital (2007), Medical Oncology Research Interest Lung Cancer, Clinical and Translational Research Oncology Outcomes Publications Patient Perspectives on Electronic Communication of Cancer Diagnoses Bhalla S, Patel MJ, Abruzzo L, Christie A, Garg R, Xie D, Louissaint J, Zhang S, Kitzman H, Gerber DE JAMA Network Open 2026 Jun 9 Correction: Metabolic syndrome and immune-related adverse events (Cancer Immunology, Immunotherapy, (2026), 75, 2, (39), 10.1007/s00262-025-04276-w) Lei K, Patel MJ, Liu J, Rathod RA, von Itzstein MS, Fattah F, Mu-Mosley H, SoRelle JA, Park JY, Xie Y, Hughes AE, Kitzman H, Gerber DE Cancer Immunology, Immunotherapy 2026 Jun 75 Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials Wang Y, Sun Z, Sridhar A, Ramalingam SS, Wakelee HA, Gerber DE Lung Cancer 2026 Apr 214 Immune Checkpoint Inhibitor Outcomes in NSCLC Across Populations and Practice Settings Lee M, Liu J, Teigen KJ, Sabloak K, Howell M, Gonzalez M, Ghabach B, Gerber DE, Narra K, von Itzstein MS JTO Clinical and Research Reports 2026 Apr 7 Prostate cancer-related genetic counseling in a safety-net healthcare setting Mbonu P, Mersch J, Heady J, Newman S, Bullock JC, Seymour K, Gerber DE, Narra K Urologic Oncology: Seminars and Original Investigations 2026 Mar 44 A new therapeutic approach to KRAS mutant non-small cell lung cancer: the emerging role of exportin 1 inhibition von Itzstein MS, Gerber DE Translational Lung Cancer Research 2026 Feb 15 Radiologists’ Perceptions of the 21st Century Cures Act Porembka JH, Paton EL, Xi Y, Carlos RC, Bhalla S, Cetnar JP, Makhnoon S, Krishnaraj A, Rubin EM, Gerber DE Journal of the American College of Radiology 2026 Feb 23 276-280 Metabolic syndrome and immune-related adverse events Lei K, Patel MJ, Liu J, Rathod RA, von Itsztein MS, Fattah F, Mu-Mosley H, SoRelle JA, Park JY, Xie Y, Hughes AE, Kitzman H, Gerber DE Cancer Immunology, Immunotherapy 2026 Feb 75 Health Beliefs and Adherence to Lung Cancer Screening in a Diverse Safety-Net Population Bhalla S, Hamann H, Prasad T, Mullins MA, Malone ST, Rodriguez J, Gwin ME, Natchimuthu V, Nair RG, Ibekwe-Agunanna LN, Craddock Lee SJ, Johnson DH, Wahid U, Gao A, Zhang S, Gerber DE JNCCN Journal of the National Comprehensive Cancer Network 2026 Jan 24 Resistance to Immune Checkpoint Inhibitor Treatment in Non–Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators Doroshow DB, Leal TA, Waqar SN, Borghaei H, Camidge DR, Dragnev KH, Edelman MJ, Gandara DR, Gerber DE, Gray JE, Hirsch FR, Husain H, Kozono DE, Leighl NB, Li BT, Mack PC, Neal JW, Paik PK, Patel SP, Riess JW, Redman MW, Reckamp KL Journal of Clinical Oncology 2026 Results 1-10 of 302 1 2 3 4 5 Next Last Books Featured Books Targeted Therapies for Non-Small Cell Lung Cancer David E. Gerber (2011). Oxford University Press Lung Cancer Apar K. Ganti, David E. Gerber (Ed.) (2014). Oxford University Press Honors & Awards National Cancer Institute(NCI) Director's Award (2023) Leaders in Clinical Excellence Mentoring AwardUT Southwestern (2022) Exceptional Research in Navigation AwardAcademy of Oncology Nurse & Patient Navigators (2018) National Cancer Institute (NCI)Midcareer Investigator Award in Patient-Oriented Research (2016) Top DoctorsCastle Connolly (2015-2023) Best Doctors in DallasD Magazine (2011-2023) Clinical Investigator Team Leadership AwardNational Cancer Institute (2011) Career Development AwardAmerican Society of Clinical Oncology (2009) Professional Associations/Affiliations American Society of Clinical Oncology Dallas County Medical Society Eastern Cooperative Oncology Group International Association for the Study of Lung Cancer Texas Medical Association
